T. Rowe Price Associates’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-148,439
| Closed | -$10.7M | – | 2907 |
|
|
2020
Q4 | $10.7M | Sell |
148,439
-423,015
| -74% | -$22.1M | ﹤0.01% | 1342 |
|
|
2020
Q3 | $26M | Buy |
571,454
+2,946
| +0.5% | +$123K | ﹤0.01% | 1079 |
|
|
2020
Q2 | $25.7M | Sell |
568,508
-7,920
| -1% | -$355K | ﹤0.01% | 1072 |
|
|
2020
Q1 | $22.2M | Sell |
576,428
-2,466
| -0.4% | -$114K | ﹤0.01% | 1035 |
|
|
2019
Q4 | $26.8M | Sell |
578,894
-999
| -0.2% | -$43.3K | ﹤0.01% | 1093 |
|
|
2019
Q3 | $23.6M | Sell |
579,893
-6,130
| -1% | -$265K | ﹤0.01% | 1102 |
|
|
2019
Q2 | $28.2M | Buy |
586,023
+2,709
| +0.5% | +$142K | ﹤0.01% | 1072 |
|
|
2019
Q1 | $36.5M | Buy |
583,314
+30,360
| +5% | +$2.09M | 0.01% | 985 |
|
|
2018
Q4 | $33M | Buy |
552,954
+46,802
| +9% | +$2.81M | 0.01% | 974 |
|
|
2018
Q3 | $32.6M | Buy |
506,152
+10,607
| +2% | +$592K | ﹤0.01% | 1063 |
|
|
2018
Q2 | $22.3M | Buy |
495,545
+38,222
| +8% | +$1.52M | ﹤0.01% | 1167 |
|
|
2018
Q1 | $14.2M | Buy |
457,323
+11,068
| +2% | +$364K | ﹤0.01% | 1281 |
|
|
2017
Q4 | $13.3M | Buy |
446,255
+4,427
| +1% | +$128K | ﹤0.01% | 1288 |
|
|
2017
Q3 | $14.6M | Buy |
441,828
+178,727
| +68% | +$6.19M | ﹤0.01% | 1274 |
|
|
2017
Q2 | $8.8M | Buy |
263,101
+251,326
| +2,134% | +$7.5M | ﹤0.01% | 1342 |
|
|
2017
Q1 | $341K | Sell |
11,775
-9
| -0.1% | -$223 | ﹤0.01% | 2203 |
|
|
2016
Q4 | $263K | Hold |
11,784
| – | – | ﹤0.01% | 2295 |
|
|
2016
Q3 | $219K | Hold |
11,784
| – | – | ﹤0.01% | 2324 |
|
|
2016
Q2 | $192K | Sell |
11,784
-16
| -0.1% | -$235 | ﹤0.01% | 2342 |
|
|
2016
Q1 | $138K | Hold |
11,800
| – | – | ﹤0.01% | 2369 |
|
|
2015
Q4 | $138K | Buy |
+11,800
| New | +$149K | ﹤0.01% | 2373 |
|
|
2013
Q3 | – | Sell |
-21,100
| Closed | -$124K | – | 2512 |
|
|
2013
Q2 | $124K | Buy |
+21,100
| New | +$71K | ﹤0.01% | 2304 |
|
Other funds holding BEAT
T. Rowe Price Associates's BEAT Position: Q1 2021 in Review
T. Rowe Price Associates sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 148,439 shares — an estimated $10.7M sold.
T. Rowe Price Associates first reported a position in BEAT in Q2 2013 and held it in 22 quarters. The position peaked at $36.5M in Q1 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- T. Rowe Price Associates reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- T. Rowe Price Associates sold 148,439 BioTelemetry, Inc. shares in Q1 2021, an estimated $10.7M.
- T. Rowe Price Associates first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 22 quarters.
- T. Rowe Price Associates's BioTelemetry, Inc. position peaked at $36.5M in Q1 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.